|Bid||2.9500 x 0|
|Ask||3.0500 x 0|
|Day's Range||2.9800 - 3.0800|
|52 Week Range||1.6600 - 13.9600|
|Beta (5Y Monthly)||1.65|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TORONTO, August 02, 2022--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) ("Greenbrook" or the "Company"), today announced its second quarter 2022 ("Q2 2022") operational and financial results. All values in this press release are in United States dollars, unless otherwise stated.
TORONTO, July 27, 2022--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) ("Greenbrook" or the "Company"), will release its 2022 second quarter operational and financial results after market hours on August 2, 2022.
TORONTO, July 14, 2022--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, is pleased to announce the closing of its previously-announced acquisition (the "Acquisition") of Check Five LLC, a Delaware limited liability company (doing business as "Success TMS") ("Success TMS"). In addition, Greenbrook announces today that it and its subsidiaries have entered into a credit agree